SC 13G
SABBY 13G ESPR 12.09.21
- Company
- Esperion Therapeutics, Inc.
- Filed
- December 9, 2021
- Accession Number
- 0001535610-21-000104
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →